Learn More
Medchemexpress LLC 2-propenamide, N-[3-[2-[[4-[2-(dimethylamino)ethoxy]-2-methoxyphenyl]amino]...], trifluoroacetate | 2753348-63-7 | 99.4% | 628.60 | C30H31F3N6O6 | 10 MG

Supplier: Medchemexpress LLC HY19617B10MG
EGFR-IN-1 TFA is an orally active, irreversible small-molecule inhibitor selective for L858R/T790M mutant forms of the epidermal growth factor receptor (EGFR). It potently inhibits gefitinib-resistant EGFR mutants and demonstrates antiproliferative activity in mutant EGFR cell lines, making it suitable for cellular assays and preclinical research.
- High mutant selectivity for L858R/T790M.
- Irreversible mode of inhibition.
- Potent antiproliferative activity in cell models.
- Supplied as a trifluoroacetate salt for stability.
- Intended for in vitro and preclinical research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.